306 related articles for article (PubMed ID: 11850139)
1. Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels.
Gonzalez S; Fernandez-Ruiz J; Sparpaglione V; Parolaro D; Ramos JA
Drug Alcohol Depend; 2002 Mar; 66(1):77-84. PubMed ID: 11850139
[TBL] [Abstract][Full Text] [Related]
2. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.
González S; Cascio MG; Fernández-Ruiz J; Fezza F; Di Marzo V; Ramos JA
Brain Res; 2002 Nov; 954(1):73-81. PubMed ID: 12393235
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide.
Romero J; Berrendero F; García-Gil L; Lin SY; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
Neurochem Int; 1999 Jun; 34(6):473-82. PubMed ID: 10402222
[TBL] [Abstract][Full Text] [Related]
4. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
[TBL] [Abstract][Full Text] [Related]
5. Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats.
Berrendero F; Romero J; García-Gil L; Suarez I; De la Cruz P; Ramos JA; Fernández-Ruiz JJ
Biochim Biophys Acta; 1998 Sep; 1407(3):205-14. PubMed ID: 9748581
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
[TBL] [Abstract][Full Text] [Related]
7. Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats.
González S; Schmid PC; Fernández-Ruiz J; Krebsbach R; Schmid HH; Ramos JA
Addict Biol; 2003 Jun; 8(2):159-66. PubMed ID: 12850774
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
[TBL] [Abstract][Full Text] [Related]
9. The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat.
Turchan J; Przewłocka B; Toth G; Lasoń W; Borsodi A; Przewłocki R
Neuroscience; 1999; 91(3):971-7. PubMed ID: 10391475
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period.
Berrendero F; Sepe N; Ramos JA; Di Marzo V; Fernández-Ruiz JJ
Synapse; 1999 Sep; 33(3):181-91. PubMed ID: 10420166
[TBL] [Abstract][Full Text] [Related]
11. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry.
Mailleux P; Vanderhaeghen JJ
Neuroscience; 1992; 48(3):655-68. PubMed ID: 1376455
[TBL] [Abstract][Full Text] [Related]
12. Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland.
González S; Manzanares J; Berrendero F; Wenger T; Corchero J; Bisogno T; Romero J; Fuentes JA; Di Marzo V; Ramos JA; Fernández-Ruiz J
Neuroendocrinology; 1999 Aug; 70(2):137-45. PubMed ID: 10461028
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor binding and mRNA levels in several brain regions of adult male and female rats perinatally exposed to delta9-tetrahydrocannabinol.
García-Gil L; Romero J; Ramos JA; Fernández-Ruiz JJ
Drug Alcohol Depend; 1999 Jun; 55(1-2):127-36. PubMed ID: 10402157
[TBL] [Abstract][Full Text] [Related]
14. Reflections on: "A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function".
Nestler EJ
Brain Res; 2016 Aug; 1645():71-4. PubMed ID: 26740398
[TBL] [Abstract][Full Text] [Related]
15. Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis.
Berrendero F; Sánchez A; Cabranes A; Puerta C; Ramos JA; García-Merino A; Fernández-Ruiz J
Synapse; 2001 Sep; 41(3):195-202. PubMed ID: 11391780
[TBL] [Abstract][Full Text] [Related]
16. NGFI-B and nor1 mRNAs are upregulated in brain reward pathways by drugs of abuse: different effects in Fischer and Lewis rats.
Werme M; Olson L; Brené S
Brain Res Mol Brain Res; 2000 Mar; 76(1):18-24. PubMed ID: 10719211
[TBL] [Abstract][Full Text] [Related]
17. Functional interaction between opioid and cannabinoid receptors in drug self-administration.
Navarro M; Carrera MR; Fratta W; Valverde O; Cossu G; Fattore L; Chowen JA; Gomez R; del Arco I; Villanua MA; Maldonado R; Koob GF; Rodriguez de Fonseca F
J Neurosci; 2001 Jul; 21(14):5344-50. PubMed ID: 11438610
[TBL] [Abstract][Full Text] [Related]
18. Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940.
Rubino T; Viganò D; Massi P; Parolaro D
J Neurochem; 2000 Nov; 75(5):2080-6. PubMed ID: 11032897
[TBL] [Abstract][Full Text] [Related]
19. Alcohol consumption alters dopamine transporter sites in Wistar-Kyoto rat brain.
Jiao X; Paré WP; Tejani-Butt SM
Brain Res; 2006 Feb; 1073-1074():175-82. PubMed ID: 16457790
[TBL] [Abstract][Full Text] [Related]
20. Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain.
Viganò D; Grazia Cascio M; Rubino T; Fezza F; Vaccani A; Di Marzo V; Parolaro D
Neuropsychopharmacology; 2003 Jun; 28(6):1160-7. PubMed ID: 12637958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
